Cerus reported $-11126000 in EBIT for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Atrion ATRI:US 9.48M 317K
Cerulean Pharma CERU:US $ -12668940 3.51M
Cerus CERS:US $ -11126000 3.28M
Cytori Therapeutics CYTX:US $ -3481000 906K
GRIFOLS GRF:SM 245.2M 40.86M
Haemonetics HAE:US $ 32.39M 6.86M
Meridian Bioscience VIVO:US $ 13.75M 2.67M
Neogen NEOG:US $ 12.47M 9.28M
Nuvasive NUVA:US $ -2082000 24.38M
Orasure Technologies OSUR:US $ -13513000 15.09M
Quidel QDEL:US $ 281.84M 257.51M
Rockwell Medical RMTI:US -6972000 851K
Sientra SIEN:US $ -11694000 2.54M
Staar Surgical STAA:US $ 7.84M 2.81M
Terumo 4543:JP 29.62B 6.61B